Search
XL844
go.drugbank.com/drugs/DB05149InvestigationalXL844 is a potent inhibitor of the checkpoint kinases CHK1 and CHK2, which induce cell cycle arrest in response to a variety of DNA damaging agents.
Suxibuzone
go.drugbank.com/drugs/DB13232ExperimentalCategories: Analgesics, Non-Narcotic, Non COX-2 selective NSAIDSPirprofen
go.drugbank.com/drugs/DB13722ExperimentalCategories: Analgesics, Non-Narcotic, Non COX-2 selective NSAIDSAGT-182
go.drugbank.com/drugs/DB17630InvestigationalAGT-182 is an investigational enzyme replacement therapy engineered by the fusion of the iduronate-2-sulfatase (IDS) enzyme and a human insulin receptor monoclonal antibody.
TAK-611
go.drugbank.com/drugs/DB17644InvestigationalFirst developed by Takeda, it is being investigated for the treatment of metachromatic leukodystrophy.
Imexon
go.drugbank.com/drugs/DB05003InvestigationalIt belongs to the family of drugs called cyanoaziridine derivatives. Also called Amplimexon. Imexon is a cyanoaziridine derivative. … Imexon is a thiol-binding small molecule which induces mitochondrial oxidation, a loss of membrane potential and cytochrome C, leading to apoptosis.
PX-478
go.drugbank.com/drugs/DB06082InvestigationalPX-478 was effective in models of both non-small cell lung cancer and small cell lung cancer that express HIF-1 alpha.
Fenclofenac
go.drugbank.com/drugs/DB21391ExperimentalFenclofenac is a small molecule drug. The usage of the INN stem '-ac' in the name indicates that Fenclofenac is a anti-inflammatory agent, ibufenac derivative. Fenclofenac has a monoisotopic molecular weight of 296.0 Da.
Categories: Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-SteroidalInactivated SARS-Cov-2 Vaccine
go.drugbank.com/drugs/DB15862InvestigationalDeveloped by Sinopharm's Wuhan Institute of Biological Products co., this vaccine consists of the WIV04 strain of SARS-CoV-2.